Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Recruiting 2Terminated 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Advanced Solid Tumors 10Solid Tumors 8Solid Tumor 8Unspecified Adult Solid Tumor, Protocol Specific 7Mesothelioma 6Mesothelioma, Malignant 3Advanced Solid Tumor 3Advanced/Metastatic Solid Tumors 2Advanced Solid Tumour 2Uterine Neoplasms 1Unspecified Childhood Solid Tumor, Protocol Specific 1Unspecified Adult Solid Tumor 1Triple Negative Breast Neoplasms 1Solitary Fibrous Tumor, Pleural 1Solid Tumor, Adult 1Select Advanced Solid Tumors 1Refractory Solid Tumors in Children 1Ovarian Neoplasms 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Malignant Solid Tumour 1MSI-H Advanced Colorectal Cancer 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Cervical Adenocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Neuroendocrine 1Carcinoma, Merkel Cell 1Breast Neoplasms 1Advanced HCC 1

Interventions

Injections 26toripalimab 17pembrolizumab 17tislelizumab 12Gemcitabine 8Cisplatin 7spartalizumab 6atezolizumab 6Irinotecan 6Carboplatin 6Paclitaxel 5Oxaliplatin 5Nivolumab 5Leucovorin 5Fluorouracil 5camrelizumab 4Pemetrexed 4Docetaxel 4Cetuximab 4Capecitabine 4trastuzumab deruxtecan 3sintilimab 3olaparib 3lenvatinib 3cediranib 3PM 01183 3Drug Therapy 3Cyclophosphamide 3Bevacizumab 3Albumin-Bound Paclitaxel 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Advanced Solid Tumor × Bevacizumab × Other solid neoplasm × Clear all
NCT06233942 2026-06-05

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

BeOne Medicines

Phase 1 Recruiting
308 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06509906 2025-12-18

M9466 in Combination With Topoisomerase 1 Inhibitors-based Regimens in Advanced Solid Tumors and Colorectal Cancer (DDRiver 511)

EMD Serono

Phase 1 Terminated
3 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT06139211 2024-12-20

A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

Shanghai Junshi Bioscience Co., Ltd.

Phase 1/2 Recruiting
186 enrolled
Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡